Pharmacodynamic Studies of Vancomycin, Metronidazole and Fusidic Acid against Clostridium difficile

Publisher： Karger

E-ISSN： 1421-9794|53|4|267-274

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.4, 2007-06, pp. : 267-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro Activity of Rifaximin, Metronidazole and Vancomycin against Clostridium difficile and the Rate of Selection of Spontaneously Resistant Mutants against Representative Anaerobic and Aerobic Bacteria, Including Ammonia-Producing Species

By  

Chemotherapy, Vol. 46, Iss. 4, 2000-06 ,pp. : 253-266

Karger

Access to resources Recommend Favorite

The Enterotoxicity of Clostridium difficile Toxins

By Sun Xingmin   Savidge Tor   Feng Hanping  

Toxins, Vol. 2, Iss. 7, 2010-07 ,pp. : 1848-1880

MDPI

Access to resources Recommend Favorite

Flooding and Clostridium difficile Infection: A Case-Crossover Analysis

By Lin Cynthia J.   Wade Timothy J.   Hilborn Elizabeth D.  

International Journal of Environmental Research and Public Health, Vol. 12, Iss. 6, 2015-06 ,pp. : 6948-6964

MDPI

Access to resources Recommend Favorite

A Review of Management of Clostridium difficile Infection: Primary and Recurrence

By Vincent Yasmeen   Manji Arif   Gregory-Miller Kathleen   Lee Christine  

Antibiotics, Vol. 4, Iss. 4, 2015-09 ,pp. : 411-423

MDPI

Access to resources Recommend Favorite

Advances in the Microbiome: Applications to Clostridium difficile Infection

By Culligan Eamonn P.   Sleator Roy D.  

Journal of Clinical Medicine, Vol. 5, Iss. 9, 2016-09 ,pp. : 83-83

MDPI

Access to resources Recommend Favorite